The different results for these two cancer subtypes may reflect the smaller number of FTC patients, which reduced the power of the analysis, or may reflect the differences in the aetiology of these tumours, since alterations of the RET signalling pathway are commonly found in PTC, but not FTC [7]. This evidence concerns the gene RET and thyroid cancer, nonmedullary, 2.